Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIC | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | WDR7 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | REEP1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | ZNF428 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | ADSSL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
mRNA | TMEFF1 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
mRNA | NCF4 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | DLX3 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | MS4A18 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |